Evaluation of potential liver donors: expanding donor criteria?
Rull
R
R
Liver Transplant Unit, Hospital Clinic, I Provincial de Barcelona, Barcelona, Spain.
García-Valdecasas
J C
JC
Momblan
D
D
Grande
L
L
Vidal
O
O
Fuster
J
J
González
F X
FX
López-Boado
M A
MA
Cabrer
K
K
Visa
J
J
D000241:Adenosine; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000493:Allopurinol; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005978:Glutathione; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007328:Insulin; D008099:Liver; D016031:Liver Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D009926:Organ Preservation / Q000379:methods; D019188:Organ Preservation Solutions; D011336:Probability; D011887:Raffinose; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D016572:Cyclosporine; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose; D008775:Methylprednisolone